Abstract:Introduction: Given the direct association with malignant ventricular arrhythmias, cardiotoxicity is a major concern in drug design. In the past decades, computational models based on the quantitative structure–activity relationship have been proposed to screen out cardiotoxic compounds and have shown promising results. The combination of molecular fingerprint and the machine learning model shows stable performance for a wide spectrum of problems; however, not long after the advent of the graph neural network (GNN) deep learning model and its variant (e.g., graph transformer), it has become the principal way of quantitative structure–activity relationship-based modeling for its high flexibility in feature extraction and decision rule generation. Despite all these progresses, the expressiveness (the ability of a program to identify non-isomorphic graph structures) of the GNN model is bounded by the WL isomorphism test, and a suitable thresholding scheme that relates directly to the sensitivity and credibility of a model is still an open question. Methods: In this research, we further improved the expressiveness of the GNN model by introducing the substructure-aware bias by the graph subgraph transformer network model. Moreover, to propose the most appropriate thresholding scheme, a comprehensive comparison of the thresholding schemes was conducted. Results: Based on these improvements, the best model attains performance with 90.4% precision, 90.4% recall, and 90.5% F1-score with a dual-threshold scheme (active: <1μM ; non-active: >30μM ). The improved pipeline (graph subgraph transformer network model and thresholding scheme) also shows its advantages in terms of the activity cliff problem and model interpretability.

Graph signal processing based nonlinear QSAR/QSPR model learning for compounds

QSAR modeling based on graph neural networks

Hyperbolic relational graph convolution networks plus: a simple but highly efficient QSAR-modeling method

Graph Self-Supervised Learning for Optoelectronic Properties of Organic Semiconductors

QSAR Classification Modeling for Bioactivity of Molecular Structure via SPL-Logsum

Could graph neural networks learn better molecular representation for drug discovery? A comparison study of descriptor-based and graph-based models

QSPR study for compounds with diversity structures

Graph neural networks for the prediction of molecular structure-property relationships

Hybridizing Feature Selection and Feature Learning Approaches in QSAR Modeling for Drug Discovery

Treat Molecular Linear Notations as Sentences: Accurate Quantitative Structure-Property Relationship Modeling via a Natural Language Processing Approach

Graph Multi-Similarity Learning for Molecular Property Prediction

Regression Methods For Developing Qsar And Qspr Models To Predict Compounds Of Specific Pharmacodynamic, Pharmacokinetic And Toxicological Properties

QSPR Modeling of Bioconcentration Factor of Nonionic Compounds Using Gaussian Processes and Theoretical Descriptors Derived from Electrostatic Potentials on Molecular Surface.

Molecular Graph Encoding Convolutional Neural Networks for Automatic Chemical Feature Extraction.

An Inverse QSAR Method Based on Linear Regression and Integer Programming

Descriptor Selection Via Log-Sum Regularization for the Biological Activities of Chemical Structure

An Architecture of Deep Learning in QSPR Modeling for the Prediction of Critical Properties Using Molecular Signatures

On the QSAR-based cardiotoxicity modeling: with expressiveness-enhanced graph learning model and dual-threshold scheme

Comprehensive ensemble in QSAR prediction for drug discovery

Molecular Graph Representation Learning via Structural Similarity Information

Molecular substructure graph attention network for molecular property identification in drug discovery